About Amryt Pharma
Amryt Pharma is a company based in Dublin (Ireland) founded in 2015 was acquired by Chiesi Pharmaceuticals in January 2023.. Amryt Pharma has completed 4 acquisitions, including Aegerion, Birken and Chiasma. Amryt Pharma offers products and services including Juxtapid / Lojuxta, Myalept / Myalepta, and Mycapssa. Amryt Pharma operates in a competitive market with competitors including Castle Creek Biosciences, QID Pharma, Eicos Sciences and LifeMax, among others.
- Headquarter Dublin, Ireland
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amryt Pharma Plc
-
Annual Revenue
$239.89 M51as on Dec 31, 2015
-
Net Profit
$-73.34 M-86as on Dec 31, 2015
-
EBITDA
$-45.19 M-69as on Dec 31, 2015
-
Latest Funding Round
$40 M (USD), Post-IPO
Dec 08, 2020
-
Investors
European Investment Bank
& 7 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Aegerion
& 3 more
-
Acquired by
Chiesi Pharmaceuticals
(Jan 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amryt Pharma
Amryt Pharma offers a comprehensive portfolio of products and services, including Juxtapid / Lojuxta, Myalept / Myalepta, and Mycapssa. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for homozygous familial hypercholesterolaemia and related conditions.
Therapy for lipodystrophy and metabolic disorders.
Management for acromegaly and hormonal imbalances.
Unlock access to complete
Funding Insights of Amryt Pharma
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $40.0M
-
First Round
First Round
(19 Apr 2016)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Post-IPO - Amryt Pharma | Valuation |
investors |
|
| Sep, 2019 | Amount | Post-IPO - Amryt Pharma | Valuation |
investors |
|
| Dec, 2018 | Amount | Grant - Amryt Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amryt Pharma
Amryt Pharma has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, Chiesi Pharmaceuticals and Government. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
StonePine Capital Partners is focused on private equity investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amryt Pharma
Amryt Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Aegerion, Birken and Chiasma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Somatostatin analogue peptides are developed for rare neuroendocrine diseases.
|
2012 | ||||
|
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
2005 | ||||
|
Therapies for rare diseases are developed via oral platform technology.
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Amryt Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amryt Pharma Comparisons
Competitors of Amryt Pharma
Amryt Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Creek Biosciences, QID Pharma, Eicos Sciences and LifeMax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform for rare disease treatments is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic dermatology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Develops Prostacyclin-based therapies for underserved medical conditions globally.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutic solutions for Netherton syndrome treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amryt Pharma
Frequently Asked Questions about Amryt Pharma
When was Amryt Pharma founded?
Amryt Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Amryt Pharma located?
Amryt Pharma is headquartered in Dublin, Ireland.
Who is the current CEO of Amryt Pharma?
Joe Wiley is the current CEO of Amryt Pharma.
What is the annual revenue of Amryt Pharma?
Annual revenue of Amryt Pharma is $239.89M as on Dec 31, 2015.
What does Amryt Pharma do?
Amryt Pharma was founded in 2015 and is headquartered in Dublin, Ireland. Therapeutics for rare and orphan diseases, particularly in dermatology, are developed by the company. Treatments such as Juxtapid for homozygous familial hypercholesterolemia and Myalepta for lipodystrophy have been created. Products addressing hereditary skin disorders like epidermolysis bullosa are also included in its portfolio. Operations center on pharmaceutical research and development for underserved patient populations.
Who are the top competitors of Amryt Pharma?
Amryt Pharma's top competitors include Castle Creek Biosciences, QID Pharma and Eicos Sciences.
What products or services does Amryt Pharma offer?
Amryt Pharma offers Juxtapid / Lojuxta, Myalept / Myalepta, and Mycapssa.
How many acquisitions has Amryt Pharma made?
Who are Amryt Pharma's investors?
Amryt Pharma has 8 investors. Key investors include European Investment Bank, Chiesi Pharmaceuticals, Government, Amati Global Investors, and StonePine Capital Partners.